Artha Sootra - Company Dashboard

Governance Classic Home

Alivus Life Sciences LtdPharmaceuticalsINE03Q201024Standalone₹1520.90+40.70 (+2.75%)

Valuation

Market Cap₹18.66K Cr

TTM PE27.88x

Forward PE26.97x

PEG2.53

Book Value₹295.85

P/B5.14x

TTM EPS₹54.54

Fwd EPS₹56.39

TTM Revenue₹2.68K Cr

TTM PAT₹669.75 Cr

TTM EBITDA₹922.71 Cr

TTM EBIT₹840.44 Cr

Last Qtr PAT₹196.75 Cr

Last Qtr EBITDA₹265.19 Cr

Last Qtr EBIT₹243.37 Cr

Profitability

ROE18.44%

ROCE24.00%

TTM NPM24.95%

TTM EBITDA %34.37%

Curr OPM28.03%

Last OPM24.15%

Curr NPM—

Last NPM—

Curr EPS₹16.02

Last EPS₹13.04

Balance sheet

Equity₹24.55 Cr

Reserve₹3.61K Cr

Total Debt₹52.90 Cr

D/E0.01x

Interest %0.67%

Curr Interest₹1.31 Cr

Price / range

Close₹1520.70

vs 52W High-0.54%

vs 52W Low+83.22%

MA50—

MA200—

Returns

1D+2.66%

1W+8.60%

1M+10.82%

3M+13.77%

6M+42.43%

1Y+67.91%

2Y+41.92%

3Y+145.27%

5Y—

Diwali+67.56%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1773.40	₹4.25L Cr	130.40	3.70%
DIVISLAB	10037.50	₹2.66L Cr	90.60	17.55%
TORNTPHARM	4738.50	₹1.60L Cr	83.32	11.07%
LAURUSLABS	2323.80	₹1.25L Cr	120.09	17.24%
ZYDUSLIFE	1188.10	₹1.20L Cr	38.84	11.33%
DRREDDY	1374.00	₹1.15L Cr	413.86	2.50%
CIPLA	1402.00	₹1.13L Cr	42.73	7.49%
MANKIND	2537.90	₹1.05L Cr	45.48	13.10%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Sep-26	Jun-26	Mar-26	Dec-25	Sep-25	FY25-26
Revenue	681.99+16.0%	640.41	689.12	672.89	587.98	2,551.83
Other Income	19.92	22.40	22.78	13.93	14.72	60.41
Total Income	701.90+16.5%	662.82	711.90	686.82	602.70	2,612.24
Interest	1.31	1.31	1.31	1.49	1.32	5.37
Expenditure	-439.93-2.7%	-450.59	-496.10	-462.77	-428.56	-1,835.28
PBDT	0	0	0	0	0	0
EBITDA	265.19+48.0%	211.72	214.53	231.27	179.18	797.28
Depreciation	-21.82	-20.59	-20.20	-19.66	-18.44	-75.36
EBIT	243.37+51.4%	191.13	194.33	211.61	160.74	721.92
PBT	261.97+50.4%	212.22	215.80	198.39	174.14	751.31
Tax	-65.23	-52.15	-53.14	-48.13	-44.11	-186.83
Equity	24.55	24.55	24.55	24.54	0	24.55
OPM	37.32	32.02	30.31	28.89	29.62	28.76
Net Profit	196.75+51.3%	160.08	162.66	150.26	130.03	564.48
NPM	28.03	24.15	22.85	21.88	22.11	21.61
EPS	16.02+51.1%	13.04	13.23	12.25	10.60	45.99

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23
Revenue	2,551.83+6.9%	2,386.88+4.5%	2,283.21+5.6%	2,161.22
Other Income	60.41	34.57	12.04	28.96
Total Income	2,612.24+7.9%	2,421.45+5.5%	2,295.26+4.8%	2,190.18
Expenditure	-1,835.28-3.8%	-1,767.32-6.2%	-1,663.97-6.6%	-1,561.57
Interest	-5.37	-2.41	-1.55	-0.55
PBDT	0	0	0	0
EBITDA	797.28+16.8%	682.58+1.2%	674.24+5.0%	642.29
Depreciation	-75.36	-60.61	-53.45	-42.09
EBIT	721.92+16.1%	621.97+0.2%	620.79+3.4%	600.20
PBT	751.31+14.9%	654.13+3.6%	631.29+0.4%	628.61
Tax	-186.83	-168.50	-160.40	-161.65
Equity	24.55	24.51	0	0
OPM (%)	28.76	27.01	28.00	29.00
Net Profit	564.48+16.2%	485.63+3.1%	470.89+0.8%	466.96
NPM (%)	21.61	20.06	21.00	21.00
EPS (Rs)	45.99+16.0%	39.63+3.1%	38.43+0.8%	38.11
CEPS	45.90	39.52	38.38	38.11

Metric	FY25-26
Revenue	2,551.83
Other Income	60.41
Total Income	2,612.24
Interest	5.37
Expenditure	-1,835.28
PBDT	0
EBITDA	797.28
Depreciation	-75.36
EBIT	721.92
PBT	751.31
Tax	-186.83
Equity	24.55
OPM	28.76
Net Profit	564.48
NPM	21.61
EPS	45.99

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25
Revenue	2,551.83+6.9%	2,386.88
Other Income	60.41	34.57
Total Income	2,612.24+7.9%	2,421.45
Expenditure	-1,835.28-3.8%	-1,767.32
Interest	-5.37	-2.41
PBDT	0	0
EBITDA	797.28+16.8%	682.58
Depreciation	-75.36	-60.61
EBIT	721.92+16.1%	621.97
PBT	751.31+14.9%	654.13
Tax	-186.83	-168.50
Equity	24.55	24.51
OPM (%)	28.76	27.01
Net Profit	564.48+16.2%	485.63
NPM (%)	21.61	20.06
EPS (Rs)	45.99+16.0%	39.63
CEPS	45.90	39.52

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2026	Final Dividend	5	01 Sep 2026
2025	Final Dividend	5	01 Sep 2025
2024	Interim Dividend	22.5	17 Oct 2023
2023	Interim Dividend	21	24 Mar 2023

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split